Phase 2

Marker Therapeutics Secures $13.1M Grant To Support MultiTAA Cell Therapy Trial

Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection

Galecto Starts Dosing In Mid-Stage Myelofibrosis Trial

Paratek's Antibiotic Gets FDA Orphan Drug Tag For Lung Infection

3 years ago

Galecto Starts Dosing In Mid-Stage Myelofibrosis Trial

3 years ago

DMC Recommends Biophytis Continue Sarconeos COVID-19 Study

3 years ago

Frequency Therapeutics Stock Craters After FX-322's Four Weekly Regime Shows No Benefit In Sensorineural Hearing Loss

4 years ago

DMC Recommends Biophytis Continue Sarconeos COVID-19 Study

3 years ago

|

Frequency Therapeutics Stock Craters After FX-322's Four Weekly Regime Shows No Benefit In Sensorineural Hearing Loss

4 years ago

|

AnaptysBio's Imsidolimab Fails To Separate From Placebo In Skin Blistering Disorder Study

4 years ago

|

Chimerix's DSTAT Shows Promising Results In First Cohort Of COVID-19 Study

4 years ago

|

Phase 2 Recent News

Revance Therapeutics' DaxibotulinumtoxinA For Injection Improves Muscle Tone In Mid-Stage Upper Limb Spasticity

Feb 23, 2021, 10:58 AM

|

Nektar Therapeutics Secures $150M From SFJ Pharma For New Study With BEMPEG/Pembrolizumab Combo In Head & Neck Cancer

Feb 17, 2021, 2:25 PM

|

Clene To Start Testing CNM-ZnAg In COVID-19 Patients In Brazil

Feb 16, 2021, 6:29 PM

|

Windtree Therapeutics' AEROSURF Drug Delivery Device Secures US Patent

Feb 16, 2021, 5:16 PM

|

Exelixis' Cabozantinib Data Shows Clinically Significant Benefit Versus Pfizer's Sutent, In A Type Of Kidney Cancer

Feb 16, 2021, 2:01 PM

|

Cortexyme Stops Enrollment In Mid-Stage Atuzaginstat Study In Alzheimer's Disease

Feb 16, 2021, 1:52 PM

|

Heat Biologics Cell Therapy Shows Survival Benefit In Mid-Stage Lung Cancer Study, Shares Rally

Feb 9, 2021, 1:23 PM

|

Innate Pharma To Test Lacutamab In Relapsed/Refractory Peripheral T-Cell Lymphoma Patients

Feb 9, 2021, 12:19 PM

|

Otonomy Rips 90% After Meniere's Disease Drug Achieves Primary Endpoint

Nov 9, 2017, 3:51 PM

|

Ironwood's Pipeline Needs Work, Analyst Downgrades

Jul 21, 2017, 2:47 PM

|

Getting Into The Drug Business: From NDAs To PDUFA Dates

Sep 27, 2016, 6:20 PM

|

Synthetic Biologics Crashes Following Disappointing Phase 2 Results

Feb 2, 2016, 6:36 PM

|

Novo Nordisk Announces Positive Phase 2 Trial Results, Shares Spike Higher

Feb 20, 2015, 4:14 PM

|